Mr. William Niemiec | Decision-making and Problem-solving | Best Researcher Award

Mr. William Niemiec | Decision-making and Problem-solving | Best Researcher Award

Federal University of Rio Grande do Sul, Brazil

Author Profile

Scopus 

🎓 Early Academic Pursuits

William Niemiec’s journey into the world of computer science and software engineering began with a keen interest in problem-solving and innovative system design. His formal academic pursuit took shape at the Federal University of Rio Grande do Sul (UFRGS), one of Brazil’s most esteemed institutions. Even before entering the Ph.D. program in 2024 at UFRGS’s Institute of Informatics, William was actively involved in research and academic exploration. Between 2021 and 2023, he engaged in Scientific Initiation projects, where he explored critical areas like the generalization of functionalities in health applications and data mining for software testing. These early ventures laid the foundation for his expertise in applying informatics solutions to real-world healthcare challenges.

💼 Professional Endeavors

Parallel to his academic trajectory, William Niemiec has built a robust professional career. He currently holds multiple roles in a Brazil-based software house: Project Manager, Team Lead, and Senior Software Developer. These roles are not only testament to his technical prowess but also to his leadership and management skills.

With a track record of managing around 10 industry projects, William has overseen the full lifecycle of several software systems — from design and development to deployment. His experience spans back-end, front-end, and mobile development, making him a full-stack engineer with a keen eye for user-centric design and robust architectures. His work environment often mirrors agile frameworks, emphasizing collaboration, scalability, and continuous innovation.

🔬 Contributions and Research Focus

William Niemiec’s research efforts focus on the intersection of Software Engineering and Healthcare, a domain where technology can profoundly enhance quality of life. Since 2021, he has been actively researching methods to improve health informatics, participating in health conferences and organizing collaborative workshops with healthcare professionals. His interdisciplinary approach bridges the gap between technical innovation and clinical needs.

One of his standout contributions is the design and development of a no-code platform for mHealth (mobile health) applications. This platform is structured around care plans, enabling healthcare practitioners with minimal technical knowledge to create and manage health-monitoring applications. This innovation demonstrates his commitment to democratizing digital health tools through intuitive and customizable software solutions.

In addition, his Ph.D. work investigates the use of Model-Driven Development (MDD) and Component-Based Software Engineering (CBSE) to streamline health software production. He is also exploring how Artificial Intelligence can be embedded into healthcare applications to support diagnostic and patient follow-up processes.

🏅 Accolades and Recognition

While still early in his academic career, William Niemiec has already garnered recognition for his innovative thinking and multidisciplinary collaboration. His citation index of 1 represents his early steps into impactful academic publishing, with much more expected as his Ph.D. progresses. His frequent invitations to participate in healthcare technology workshops and academic panels reflect the trust that both the academic and clinical communities place in his expertise.

🌍 Impact and Influence

William’s dual expertise in software development and health informatics allows him to play a vital role in transforming healthcare delivery through digital innovation. His research directly contributes to improving patient outcomes, enhancing clinician workflow, and bridging the tech-literacy gap in clinical settings. His mHealth initiatives are especially significant in a country like Brazil, where geographic and economic disparities often limit access to continuous care. His solutions aim to empower healthcare providers with low-code tools and to provide patients with easy-to-use applications for chronic disease management and follow-ups.

Moreover, by working closely with both technical teams and medical professionals, William facilitates cross-disciplinary dialogue, ensuring that software solutions are not only technically sound but also clinically relevant and accessible.

🌟 Legacy and Future Contributions

Looking ahead, William Niemiec is poised to become a leading voice in healthcare software engineering. With a strong foundation in academic research, professional leadership, and technical excellence, he aims to further expand his research portfolio into AI-driven clinical decision support systems and interoperable health platforms. His vision is to create sustainable and scalable digital health ecosystems that can be adapted globally, particularly in low-resource settings.

As he continues his doctoral studies and professional endeavors, William is likely to make substantial contributions to both academia and industry. His future goals include publishing in top-tier journals, mentoring emerging researchers, and influencing health policy through evidence-based digital tools.

His blend of technical mastery, managerial acumen, and human-centered research promises a career of lasting impact — not only in Brazil but across global health technology landscapes. 🌐💡

📝Notable Publications

Mobilex: A Generic Framework for Cross-Platform Mobile Development Based on Web Language

Authors: William W. Niemiec, Rafael R. Borges, Érika É. Cota

Journal/Conference: Proceedings of the 36th Brazilian Symposium on Software Engineering (SBES 2022)

Year: 2022

Dr. Jinyang Li | Decision-making and Problem-solving | Young Researcher Award

Dr. Jinyang Li | Decision-making and Problem-solving | Young Researcher Award

University of Chicago, United States

Author Profile

Google Scholar 

🌱 Early Academic Pursuits

Jinyang Li’s journey into the world of biomedical research began with a strong foundation in pharmaceutical sciences. Born on June 13, 1993, in China, he exhibited academic promise early in life. He embarked on his undergraduate education at Sichuan University, one of China’s top-tier institutions, enrolling in the West China School of Pharmacy. There, he cultivated a deep understanding of core pharmaceutical principles and began shaping his identity as a future scientist. Upon graduating in June 2015 with a Bachelor of Science in Pharmacy, he had already demonstrated an eagerness to explore the complex intersections of chemistry, biology, and medicine.

Driven by an intense curiosity and a thirst for deeper discovery, Li enrolled in a prestigious B.A. to Ph.D. program at the School of Pharmacy, Fudan University—a leading research institution in Shanghai. From September 2015 to June 2020, he pursued his Doctor of Science degree in Pharmaceutics. During this critical academic phase, he laid the groundwork for his future innovations by immersing himself in translational research, lab experimentation, and cross-disciplinary collaboration. His rigorous doctoral training honed not only his technical prowess but also his ability to approach scientific problems from multiple angles.

🧪 Professional Endeavors

After receiving his doctorate, Jinyang Li continued his scientific journey through postdoctoral research positions, first at Fudan University’s School of Basic Medical Sciences from August 2020 to March 2023. Here, he transitioned from student to early-career researcher, taking on greater responsibilities and pursuing independent research lines. His role as a postdoctoral scholar enabled him to refine his experimental design skills, expand his understanding of biophysical mechanisms, and contribute meaningfully to peer-reviewed publications.

In March 2023, Li made a significant leap in his academic career by joining the Department of Biochemistry and Molecular Biophysics at the University of Chicago, one of the United States’ most prestigious research universities. As a postdoctoral scholar in the Biological Sciences Division, he now operates at the cutting edge of molecular biology. The move not only marked his entry into the global scientific community but also signaled his growing stature as a promising international researcher. At the University of Chicago, Li has been immersed in high-level investigations, working alongside experts and mentors whose influence is shaping the next generation of biomedical discovery.

🔬 Contributions and Research Focus

Jinyang Li’s research spans an impressive range of biomedical topics, with a strong emphasis on biochemistry, molecular biophysics, and pharmaceutics. His work investigates the intricate behavior of biological molecules—unraveling the molecular mechanisms that underpin disease and drug action. Whether it’s exploring protein interactions, developing novel delivery systems for therapeutics, or elucidating cellular pathways, Li consistently demonstrates a commitment to translating fundamental science into solutions with clinical relevance.

At Fudan University, his research was focused on innovative drug delivery systems, nanotechnology applications in medicine, and pharmaceutical formulations. These endeavors not only advanced academic understanding but also laid the foundation for real-world pharmaceutical innovation. His current research at the University of Chicago likely continues this trend—bridging molecular structure with biomedical application, with potential implications in areas like cancer biology, immunotherapy, or neurodegeneration.

🏅 Accolades and Recognition

While specific awards are not detailed in the current profile, Jinyang Li’s trajectory speaks volumes about his merit. Securing postdoctoral positions at both Fudan University and the University of Chicago reflects his scientific credibility, academic discipline, and collaborative spirit. Being selected to work at globally recognized institutions is itself a testament to his research abilities and intellectual rigor. The competitive nature of postdoctoral appointments—especially at elite institutions—underscores the recognition he has earned from mentors and academic peers alike.

🌍 Impact and Influence

Jinyang Li’s impact extends beyond laboratory benches and academic publications. His research contributes to the broader scientific effort to develop more effective therapies, understand disease mechanisms at the molecular level, and inform future clinical strategies. As an international scholar working in both China and the United States, he represents a bridge between two major scientific communities—facilitating global collaboration and knowledge exchange.

Moreover, his interdisciplinary approach fosters innovation across scientific domains. His background in pharmaceutics, combined with biophysical expertise, positions him uniquely to tackle some of the most pressing health challenges of our time. In doing so, he not only advances science but also inspires younger researchers, particularly those from China aspiring to make their mark on the global stage.

🌟 Legacy and Future Contributions

Jinyang Li’s scientific career is still in its early stages, yet the foundations he has built are formidable. As he continues his work at the University of Chicago, his trajectory suggests a future filled with breakthroughs and leadership roles. His experience in two major research ecosystems equips him with a diverse and adaptive mindset—one that is critical in the ever-evolving world of biomedical science.

Looking ahead, Li is likely to contribute significantly to drug discovery, molecular diagnostics, or personalized medicine. His long-term legacy may include not just impactful publications and patents, but also mentoring emerging scientists and shaping collaborative networks between East and West. With his background, dedication, and vision, Jinyang Li is poised to become a defining figure in 21st-century biomedical research.

📝Notable Publications

Ligand-modified cell membrane enables the targeted delivery of drug nanocrystals to glioma

Authors: Z. Chai, D. Ran, L. Lu, C. Zhan, H. Ruan, X. Hu, C. Xie, K. Jiang, J. Li, J. Zhou, …
Journal: ACS Nano
Year: 2019

Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy

Authors: S. Wang, R. Wang, N. Meng, H. Guo, S. Wu, X. Wang, J. Li, H. Wang, K. Jiang, …
Journal: Journal of Controlled Release
Year: 2020

Deliver anti-PD-L1 into brain by p-hydroxybenzoic acid to enhance immunotherapeutic effect for glioblastoma

Authors: H. Guo, R. Wang, D. Wang, S. Wang, J. Zhou, Z. Chai, S. Yao, J. Li, L. Lu, Y. Liu, …
Journal: Journal of Controlled Release
Year: 2020

 Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression

Authors: S. Chen, X. Li, Y. Li, X. Yuan, C. Geng, S. Gao, J. Li, B. Ma, Z. Wang, W. Lu, …
Journal: Theranostics
Year: 2022

 All-stage precisional glioma targeted therapy enabled by a well-designed D-peptide

Authors: D. Ran, J. Zhou, Z. Chai, J. Li, C. Xie, J. Mao, L. Lu, Y. Zhang, S. Wu, C. Zhan, …
Journal: Theranostics
Year: 2020

Dr. Tam Dinh | Cross-Cultural Leadership | Best Researcher Award

Dr. Tam Dinh | Cross-Cultural Leadership | Best Researcher Award

University of New Mexico Health Sciences Center, United States

Author Profile

Orcid 

🎓 Early Academic Pursuits

Dr. Tam Dinh’s academic trajectory is marked by a strong foundation in science and an early dedication to medicine. He began his undergraduate studies at the University of California, Los Angeles, where he earned a Bachelor’s degree in Biochemistry in June 2017. This rigorous academic training laid the biochemical and analytical groundwork essential for his later clinical and research success. Driven by a desire to transition into medicine, he pursued a Post-Baccalaureate Premedical Certificate at the Keck Graduate Institute in California. This experience not only prepared him for medical school admission but also exposed him to the integration of science and industry, particularly during his team project collaboration with Eli Lilly.

His acceptance into the Frank H. Netter MD School of Medicine at Quinnipiac University marked a significant milestone. There, he distinguished himself both academically and through his involvement in scientific research. He graduated in May 2023 with a Doctor of Medicine, recognized with High Distinction in Basic, Translational, and Clinical Science, highlighting his deep commitment to evidence-based medicine and research innovation.

🩺 Professional Endeavors

Dr. Dinh’s clinical training reached a new height when he began his residency in Internal Medicine at the University of New Mexico in June 2023. Immersed in a diverse and underserved patient population in Albuquerque, he has not only deepened his clinical skills but also demonstrated leadership through mentorship and curriculum development. Notably, he is part of a team designing a new night float rotation curriculum, an initiative aimed at improving resident education and patient care during off-hours. He also took on a teaching role as a facilitator in the Internal Medicine Bootcamp’s Mock Paging Program, helping prepare fourth-year medical students for real-life clinical scenarios.

Through these experiences, Dr. Dinh has clearly embraced the dual roles of clinician and educator. His participation in the “Residents as Educators” seminar further emphasizes his intention to remain deeply engaged in teaching throughout his career.

🔬 Contributions and Research Focus

Dr. Dinh’s research portfolio is both diverse and clinically significant. From his early exploration of regulatory intelligence with Eli Lilly to his recent publications on rare diseases and autoimmune disorders, his work spans bench science, epidemiology, and quality improvement. His capstone research focused on the E3 ubiquitin ligase RNF31, where he explored cellular pathways using advanced molecular biology techniques. This project culminated in several poster presentations, including at the American College of Physicians (ACP) Annual Meeting.

Currently, his focus has shifted to autoimmune conditions affecting minority populations, including Statin-Associated Immune-Mediated Necrotizing Myopathy among Hispanic and Native American patients. This project, in collaboration with Dr. Wilmer Sibbitt Jr., is particularly impactful due to its attention to health disparities in underserved communities. Another ongoing quality improvement study with the New Mexico Veteran Affairs Health Care System aims to increase compliance with laboratory monitoring in patients on immunosuppressive therapy—an area of growing importance in managing chronic disease.

🏅 Accolades and Recognition

Throughout his career, Dr. Dinh has been recognized for both his academic excellence and scientific contributions. His publication in Therapeutic Innovation & Regulatory Science underscores his early commitment to improving healthcare delivery through innovation. At multiple stages of his training, he has presented research at high-level academic forums, such as the ACP and Society of Hospital Medicine meetings. His research abstracts have advanced in competitive settings, including the ACP Connecticut Chapter Scientific Meeting, attesting to the quality and relevance of his work.

Additionally, his leadership roles in student government, interest groups, and mentorship programs at Frank H. Netter School of Medicine reveal a consistent pattern of engagement and trust from his peers and faculty.

🌍 Impact and Influence

What sets Dr. Dinh apart is his unwavering focus on education, mentorship, and healthcare equity. As a peer support coach, a mentor in Internal Medicine, and an advocate for mental health among medical students, he has cultivated a culture of support and learning. His ability to balance clinical duties with academic and leadership responsibilities is a testament to his time management, emotional intelligence, and vision.

His clinical case presentations—ranging from Staphylococcus aureus bacteremia to rare congenital disorders—highlight his diagnostic acuity and commitment to lifelong learning. These contributions enhance the medical community’s understanding of complex pathologies and foster a culture of collaborative learning.

🌟 Legacy and Future Contributions

Looking ahead, Dr. Tam Dinh is poised to make lasting contributions to internal medicine, particularly in the realms of academic medicine, quality improvement, and health equity. His work in developing educational curricula, mentoring residents, and researching population-specific autoimmune diseases positions him as a future leader in academic internal medicine. His ability to straddle clinical care, teaching, and research so effectively ensures he will have a multifaceted impact.

With a growing body of peer-reviewed publications, increasing leadership in education reform, and continued commitment to underserved communities, Dr. Dinh’s trajectory suggests a future as a physician-scientist who not only treats illness but also transforms systems of care.

📝Notable Publications

Statin-associated immune-mediated necrotizing myopathy in Hispanic Americans

Author(s): Tam N. Dinh, Sharon E. Nunez, Kristin M. Gonzales, Krystle L. Tapia, Eric B. Garcia, Roderick A. Fields, Maheswari Muruganandam, N. Suzanne Emil, Frank X. O’Sullivan, Wilmer Sibbitt
Journal: Seminars in Arthritis and Rheumatism
Year: 2025

 Improving Compliance Rate of Monitoring Laboratory among Patients on Disease-Modifying Anti-Rheumatic Drugs at the New Mexico Veteran Affairs Health Care System

Author(s): Tam Dinh, Vijayalakshmi Kumar, Sharon Nunez, Micah Guess, Kimberly Reiter
Journal: Quality Improvement Poster Competition at University of New Mexico Hospital
Year: 2025

A Case Report on a Rare Disease: Phosphoglucomutase 3-Congenital Disorder of Glycosylation

Author(s): Tam Dinh, Osman Dokmeci
Journal: American College of Physicians New Mexico Chapter Meeting
Year: 2024

 Sepsis or no Sepsis, a Case of Staphylococcus aureus Bacteriuria and Bacteremia

Author(s): Tam Dinh, Riana Wurzburger
Journal: Society of Hospital Medicine New Mexico Chapter Meeting
Year: 2024

West Nile Virus Infection Complicated by Myocardial Infarction and Guillain-Barre Syndrome

Author(s): Tam Dinh, Daniel Mai, Pooja Viswanath, Ashley Keiler-Green
Journal: American College of Physicians New Mexico Chapter Meeting
Year: 2023

Prof Kuan-Chen Chen | Performance Management | Best Researcher Award

Prof Kuan-Chen Chen | Performance Management | Best Researcher Award

National Taipei University of Nursing and Health Sciences, Taiwan

Author Profile

Scopus

🎓 Early Academic Pursuits

Professor Kuan-Chen Chen embarked on his academic journey with a profound interest in the intricate dynamics of finance and its intersection with health care systems. He earned his Ph.D. in Finance from National Chengchi University, one of Taiwan’s most prestigious institutions known for excellence in business and social sciences. During his doctoral studies, Professor Chen exhibited a keen aptitude for analytical reasoning, quantitative modeling, and an interest in macro and micro-level financial systems. This formative academic experience laid the foundation for a career that would eventually bridge the worlds of finance and healthcare management—a rare and essential confluence in today’s complex health economies.

His early academic work reflected a deep engagement with both theoretical models and empirical data, which allowed him to develop a nuanced understanding of how financial principles could be applied to optimize healthcare operations. These academic roots inspired him to explore the evolving financial challenges of healthcare institutions and to delve into research that could influence not only academic scholarship but also real-world practices.

💼 Professional Endeavors

Currently a Professor in the Department of Health Care Management at the National Taipei University of Nursing and Health Sciences (NTUNHS), Professor Chen brings years of academic rigor and practical insight into the classroom and research laboratory. At NTUNHS, he is deeply involved in teaching, research, and academic leadership, offering specialized courses such as financial management, healthcare management, and hospital performance evaluation. These courses are designed not only to impart knowledge but to cultivate critical thinking among future healthcare managers and policymakers.

In parallel with his academic role, Professor Chen has successfully led multiple government-funded research projects, showcasing his ability to secure competitive grants and apply findings to public policy and institutional reforms. He maintains close ties with the healthcare industry, acting as a collaborative partner and advisor, which reinforces the relevance and applicability of his research.

🔬 Contributions and Research Focus

Professor Chen’s research portfolio reflects a rich blend of finance, healthcare systems, and policy evaluation. His scholarly work has notably explored working capital management, agency costs, economies of scope, and corporate social responsibility (CSR) within hospital settings.

One of his notable research projects, funded by Taiwan’s National Science Council, titled “The Impact of Working Capital Management on Financial Performance: Empirical Evidence from Hospitals in Taiwan”, addressed critical concerns surrounding liquidity and resource allocation in healthcare institutions. By empirically assessing how hospitals manage their short-term financial assets and liabilities, this study provided strategic insights into improving financial efficiency and service delivery.

Another significant project, “Agency Costs, Economies of Scope, and Corporate Social Responsibility in Hospitals,” reflects his forward-thinking approach toward integrating CSR into the operational fabric of healthcare organizations. This research explores how broader social objectives can coexist with fiscal accountability and institutional efficiency.

His citation metrics further affirm his scholarly influence:

  • Total Citations: 506

  • Citations since 2020: 309

  • h-index: 13 (10 since 2020)

  • i10-index: 15 (12 since 2020)

These figures highlight the continued relevance and reach of his research across academic and policy-making communities.

🏅 Accolades and Recognition

While Professor Chen’s career is marked by impactful research and educational contributions, he has also received recognition for his academic leadership and policy relevance. Being entrusted with multiple government-backed projects is a testament to his credibility and the confidence that both academia and public institutions place in his expertise. His role as a principal investigator in projects that examine the financial underpinnings of Taiwan’s hospital system has further established him as a thought leader in health finance.

Moreover, his active engagement with the healthcare industry reflects not just theoretical depth but also practical understanding—an invaluable combination that places him in demand as a consultant, advisor, and speaker.

🌍 Impact and Influence

Professor Chen’s work resonates not just within Taiwan but also has implications for the global discourse on healthcare economics and management. By addressing the dual imperatives of financial sustainability and quality patient care, his research contributes to international conversations on how healthcare systems can navigate the challenges of limited resources, aging populations, and rising costs.

His insights into CSR in hospitals underscore the evolving expectations of healthcare institutions—not merely as providers of clinical services but as socially responsible entities accountable to a wider array of stakeholders, including communities, regulators, and investors.

Through teaching and mentorship, Professor Chen has also cultivated a new generation of scholars and practitioners, many of whom go on to apply his models and methods in diverse institutional settings, thereby multiplying the reach of his impact.

🔮 Legacy and Future Contributions

As a respected academic and a prolific researcher, Professor Kuan-Chen Chen is poised to continue his influential work at the nexus of healthcare and financial management. His future research is likely to further explore the digital transformation of healthcare finance, value-based care models, and the role of data analytics in improving hospital performance.

With Taiwan and other nations grappling with health financing reforms, Professor Chen’s work will undoubtedly remain central to shaping policy decisions and institutional strategies. His balanced approach—grounded in rigorous analysis yet attentive to real-world application—ensures that his legacy will not only be scholarly but also deeply practical and socially relevant.

Looking ahead, he is set to expand his collaborations, possibly leading cross-national studies, and contributing to global best practices in hospital financial governance. His journey exemplifies how academic excellence, when combined with a sense of purpose, can leave an enduring imprint on both institutions and society at large. 🌟

📝Notable Publications

Healthcare utilization and costs for patients with Parkinson’s disease in Taiwan

Authors: Kuan-Chen Chen, Li-Jung Elizabeth Ku, Ya-Hui Hu, Yu Sun, Alexis Elbaz, Pei-Chen Lee

Journal: BMC Neurology

Year: 2025

Prof. Ning Yongquan | Materials Science and Engineering | Best Researcher Award

Prof. Ning Yongquan | Materials Science and Engineering | Best Researcher Award

Northwestern Polytechnical University, China

Author Profile

Google Scholar 

🎓 Early Academic Pursuits

Yongquan Ning’s academic journey began with a strong foundation in materials science and engineering, a discipline he would eventually come to master and significantly contribute to. Born on May 14, 1982, in the People’s Republic of China, Ning’s early academic promise was evident from his undergraduate years. He completed his Bachelor of Science in Materials Science and Engineering at Nanchang Hangkong University in 2005, a period during which he was already involved in hands-on research in composite materials. His undergraduate work, which explored the fabrication and thermophysical properties of SiCp/Al composites, showcased a keen interest in materials innovation and experimentation.

Driven by a thirst for deeper knowledge and technological contribution, Ning proceeded to Northwestern Polytechnical University (NPU) in Xi’an, where he earned his Master’s degree in 2008 and subsequently a Ph.D. in 2010. His doctoral research delved into the high-temperature deformation behavior and recrystallization mechanisms of powder metallurgy (P/M) superalloys, under the mentorship of the distinguished Prof. Zekun Yao. His academic career further culminated in a postdoctoral fellowship at NPU in 2011, complemented by a year as a research associate at the prestigious Hong Kong Polytechnic University. These formative years solidified his expertise and prepared him for a lifelong contribution to materials engineering. 📘🧪

🏢 Professional Endeavors

Upon the completion of his postdoctoral training, Dr. Ning took on a faculty position at the School of Materials Science and Engineering at Northwestern Polytechnical University. From his base at NPU, he launched a range of research initiatives with significant academic and industrial relevance. Among his most enduring projects has been the study and optimization of structural-gradient materials (SGMs) used in dual-property turbine disks—an innovation pivotal to aerospace engineering.

His professional work has seamlessly blended academic inquiry with applied science. Ning has actively investigated the intricate relationships between gradient-temperature-heat-treatment parameters and their impact on the microstructure and mechanical properties of advanced alloys. His understanding of microstructure transitions, particularly the control of duplex grain regions, has enabled optimization efforts that significantly enhance the dual mechanical properties needed in high-performance turbine components.

🔬 Contributions and Research Focus

Dr. Ning’s primary research focus has revolved around the development and refinement of high-performance superalloys and structural-gradient materials. His contributions to understanding microstructural evolution during thermomechanical processing, including isothermal forging and hot compression, have offered novel insights into recrystallization behaviors and grain refinement mechanisms.

His work with powder metallurgy FGH4096 superalloys between 2006 and 2010 established foundational knowledge about the internal relationships between flow behavior and initial microstructures in HIPed (Hot Isostatically Pressed) materials. Additionally, his investigations into IN718 and GH4133A superalloys under various deformation conditions have had a lasting impact on forging technologies and alloy design strategies. 🔧🧬

🏅 Accolades and Recognition

Dr. Ning’s academic excellence has been recognized consistently throughout his educational and professional career. As a student, he was the recipient of the First-Class Scholarship from NPU for four consecutive years (2006–2009), reflecting his outstanding academic performance and research achievements. In 2008, his growing expertise was acknowledged with the Second-Class Special Scholarship from the China Air-to-Air Missile Research Institute—an endorsement of both his intellectual capacity and the practical significance of his research in national defense technology.

In 2010, he was further honored with the Second-Class Chongde Scholarship awarded by the School of Materials Science and Engineering, signifying high regard from his academic community. 🏆📜

🌍 Impact and Influence

Through his research and teaching, Dr. Ning has influenced both his peers and a new generation of materials scientists. His investigations into gradient microstructures have provided critical pathways for improving dual-property materials, which are now crucial in aerospace and energy sectors. His close collaboration with both academic and industrial institutions has helped translate complex metallurgical theory into real-world engineering applications.

Furthermore, his work has added to the global body of knowledge on powder metallurgy and thermomechanical processing, enhancing the scientific community’s ability to develop materials that are lighter, stronger, and more resilient under extreme conditions. His scientific outputs not only push the boundaries of materials performance but also contribute directly to technological competitiveness in sectors vital to national and global progress. 🌐🚀

🧭 Legacy and Future Contributions

As a scholar grounded in both theory and application, Dr. Yongquan Ning’s legacy lies in his methodical approach to solving some of the most pressing challenges in materials science. With a professional ethos rooted in curiosity, precision, and innovation, he is poised to continue contributing significantly to the development of high-performance materials for aerospace, defense, and energy systems.

Looking forward, Ning is expected to deepen his research in structural-gradient materials, possibly exploring additive manufacturing integrations and AI-driven materials design—fields that align with global trends in smart manufacturing and digital engineering. Through continued mentorship, publication, and cross-disciplinary collaboration, he stands to leave an enduring mark on both academic research and industry practices. 🔭📈

📝Notable Publications

Competition between dynamic recovery and recrystallization during hot deformation for TC18 titanium alloy

Authors: Y.Q. Ning, X. Luo, H.Q. Liang, H.Z. Guo, J.L. Zhang, K. Tan
Journal: Materials Science and Engineering: A, Vol. 635, pp. 77–85
Year: 2015

Dynamic softening behavior of TC18 titanium alloy during hot deformation

Authors: Y.Q. Ning, B.C. Xie, H.Q. Liang, H. Li, X.M. Yang, H.Z. Guo
Journal: Materials & Design, Vol. 71, pp. 68–77
Year: 2015

DDRX and CDRX of an as-cast nickel-based superalloy during hot compression at γ′ sub-/super-solvus temperatures

Authors: B. Xie, H. Yu, T. Sheng, Y. Xiong, Y. Ning, M.W. Fu
Journal: Journal of Alloys and Compounds, Vol. 803, pp. 16–29
Year: 2019

Mechanisms of DRX nucleation with grain boundary bulging and subgrain rotation during the hot working of nickel-based superalloys with columnar grains

Authors: B. Xie, B. Zhang, Y. Ning, M.W. Fu
Journal: Journal of Alloys and Compounds, Vol. 786, pp. 636–647
Year: 2019

Microstructure evolution and underlying mechanisms during the hot deformation of 718Plus superalloy

Authors: B. Xie, B. Zhang, H. Yu, H. Yang, Q. Liu, Y. Ning
Journal: Materials Science and Engineering: A, Vol. 784, Article 139334
Year: 2020

Assist Prof Dr. Xianshu Qiao | Electrocatalysis | Best Researcher Award

Assist Prof Dr. Xianshu Qiao | Electrocatalysis | Best Researcher Award

Jingdezhen Ceramic University, China

Author Profile

Orcid

🌱 Early Academic Pursuits

Dr. Xianshu Qiao’s journey in materials science began with a strong foundation in chemical engineering. She earned her Master’s degree in Chemical Engineering and Technology from Inner Mongolia University of Technology, China, where she developed a keen interest in chemical processes and reaction mechanisms. Her master’s dissertation, focused on the absorption of sulfur dioxide and the preparation of barium sulfate using a triethylene glycol and dimethyl sulfoxide system, showcased her ability to tackle complex chemical challenges. This early exposure to chemical processes not only honed her analytical skills but also laid the groundwork for her future exploration of catalysis and materials science.

Her academic pursuit reached new heights when she embarked on a Ph.D. program in Materials Science and Engineering at Harbin Institute of Technology, one of China’s top technical universities. Under the mentorship of distinguished professors Wei Qin and Xiaohong Wu, Dr. Qiao focused on the preparation of iridium and iron co-modified β-Ni(OH)₂ electrode materials, with a particular emphasis on their oxygen evolution performance. Her doctoral research was marked by a meticulous approach to material design and synthesis, leading to the development of highly efficient electrode materials. These experiences not only enriched her scientific knowledge but also cemented her passion for electrocatalysis, a field that would become the core of her research career.

💡 Professional Endeavors

Dr. Xianshu Qiao’s career as an academic and researcher has been defined by her role as an Associate Professor of Materials Science at Jingdezhen Ceramic University. In this position, she has seamlessly integrated teaching, mentorship, and research, shaping the next generation of scientists while advancing the field of materials science. Her dedication to education is evident in her ability to inspire students, instilling in them a strong foundation in scientific principles and a curiosity for research.

In her research, Dr. Qiao has established herself as a leading figure in the development of transition metal-based electrocatalysts. Her work centers on the rational design, controlled synthesis, and catalytic reaction mechanisms of materials, particularly those involving nickel, iron, and cobalt compounds. Her extensive research on these materials has led to significant advancements in the efficiency of oxygen evolution reaction (OER) and hydrogen evolution reaction (HER), two critical processes for sustainable energy conversion. As a researcher, she has demonstrated a rare ability to bridge theoretical insights with practical applications, making substantial contributions to the development of efficient, durable catalysts.

🔬 Contributions and Research Focus

Dr. Xianshu Qiao’s research is characterized by a deep understanding of transition metal-based electrocatalysts, particularly those involving nickel, iron, and cobalt. Her focus on the rational design and controlled synthesis of these materials has led to the development of catalysts with exceptional performance in OER and HER. These reactions are vital for renewable energy technologies, including water splitting and hydrogen production.

Her work has resulted in numerous high-impact publications, including 13 SCI papers as the first author in internationally recognized journals such as Applied Catalysis B: Environmental, Small, International Journal of Hydrogen Energy, ACS Applied Materials and Interfaces, and Inorganic Chemistry Frontiers. These publications reflect not only her expertise in the field but also her commitment to advancing scientific knowledge. In addition to her first-author publications, she has co-authored more than 30 SCI papers, demonstrating her ability to collaborate with other researchers and contribute to multidisciplinary projects.

One of her most notable achievements is the development of porous Fe-doped β-Ni(OH)₂ nanopyramid array electrodes for water splitting, a breakthrough that has been widely recognized in the field. Her innovative approach to catalyst design, involving electronic dual modulation and grain boundary engineering, has set a new standard for the performance of transition metal-based catalysts. This work has not only advanced the understanding of catalytic mechanisms but also paved the way for the development of next-generation energy storage and conversion technologies.

🏆 Accolades and Recognition

Dr. Xianshu Qiao’s contributions to materials science have earned her significant recognition in the scientific community. Her research has been published in some of the most prestigious journals in the field, and her work on transition metal-based electrocatalysts has been widely cited by peers worldwide. Her reputation as a leading researcher is further reinforced by her extensive publication record, which includes 13 first-author SCI papers and over 30 co-authored SCI papers.

Beyond her publications, Dr. Qiao has been recognized for her ability to mentor and inspire young researchers. Her role as an educator at Jingdezhen Ceramic University has allowed her to shape the careers of aspiring scientists, fostering a culture of academic excellence and intellectual curiosity. Her dedication to scientific rigor and innovation has made her a respected figure in the academic community.

🌍 Impact and Influence

The impact of Dr. Qiao’s research extends far beyond her publications. Her innovative work on efficient electrocatalysts has the potential to drive the development of sustainable energy solutions, contributing to global efforts to combat climate change. By improving the efficiency of OER and HER, her catalysts can enhance the performance of renewable energy systems, making them more viable for large-scale applications.

As an educator and mentor, Dr. Qiao has influenced the next generation of scientists, equipping them with the skills and knowledge needed to excel in their careers. Her ability to foster a collaborative and intellectually stimulating research environment has inspired many young researchers to pursue careers in materials science.

🌟 Legacy and Future Contributions

Dr. Xianshu Qiao’s legacy is one of scientific excellence, innovation, and mentorship. Her groundbreaking research on transition metal-based electrocatalysts has transformed the field of catalysis, providing new insights into the design and optimization of efficient, durable catalysts. As she continues to explore new materials and catalytic mechanisms, her work will likely lead to further advancements in sustainable energy technologies.

In the future, Dr. Qiao is expected to expand her research into new areas of energy conversion and storage, exploring the potential of novel materials and catalytic systems. Her commitment to education and mentorship will continue to shape the careers of young scientists, ensuring that her legacy endures for generations to come.

📝Notable Publications

 Hierarchical Ultrafine Nanosheet-Based O-Doped FeCoS₂ Microsphere Catalyst for Highly Efficient Oxygen Evolution Reaction

Author: Xianshu Qiao
Journal: International Journal of Hydrogen Energy
Year: 2025

Ultra-Small β-Ni(OH)₂ Quantum Dot Catalyst with Abundant Edges for an Efficient Urea Oxidation Reaction

Author: Xianshu Qiao
Journal: Inorganic Chemistry Frontiers
Year: 2025

Modulating Electronic Structure of Iridium Single-Atom Anchored on 3D Fe-Doped β-Ni(OH)₂ Catalyst with Nanopyramid Array Structure for Enhanced Oxygen Evolution Reaction

Author: Xianshu Qiao
Journal: Small
Year: 2024

 Grain Boundary Density and Electronic Dual Modulation of Intermetallic Co₂B by Fe Doping Toward Efficient Catalyst for Oxygen Evolution Reaction

Author: Xianshu Qiao
Journal: Applied Catalysis B: Environmental
Year: 2022

Novel FeNi-Based Nanowires Network Catalyst Involving Hydrophilic Channel for Oxygen Evolution Reaction

Author: Xianshu Qiao
Journal: Small
Year: 2022

Dr. Adem soycan | Medical Microbiology | Best Researcher Award

Dr. Adem soycan | Medical Microbiology | Best Researcher Award

Kocaeli University, Institute of Health Sciences, Medical Microbiology Department, Kocaeli, Türkiye, Turkey

Author Profile

Orcid 

Early Academic Pursuits 🎓

Adem Soycan’s academic journey began with a passion for microbiology, specifically in the field of food safety. Having laid a solid foundation in biological sciences, he pursued a Bachelor’s degree in a related discipline before advancing to a Master’s program. His pursuit of knowledge led him to Kocaeli University’s Institute of Health Sciences, where he is currently a doctoral candidate in Medical Microbiology. During his academic journey, Adem has continuously sought to improve his understanding of microbial pathogens, particularly focusing on foodborne pathogens such as Shiga Toxin-Producing Escherichia coli (STEC). His rigorous research methodologies and focus on molecular diagnostics position him as a researcher with great potential for future contributions to microbiology.

Professional Endeavors 🔬

Adem Soycan’s professional endeavors are deeply intertwined with his academic pursuits. He currently serves as a doctoral candidate in Medical Microbiology at Kocaeli University, Türkiye, where he is making significant strides in the detection and study of foodborne pathogens. His expertise lies in molecular techniques such as real-time PCR, allowing for more efficient detection of pathogens, and his research on Shiga Toxin-Producing Escherichia coli (STEC) is making a notable impact in the field. He has also worked closely with local food producers, offering consultancy on pathogen detection and food safety analysis, showcasing his industry-focused approach. Adem’s interdisciplinary collaboration with Kocaeli University’s Food Safety and Microbiology Labs has further strengthened his research.

Contributions and Research Focus 🔍

Adem’s research is focused on advancing the detection and understanding of foodborne pathogens, with a special emphasis on Shiga Toxin-Producing Escherichia coli (STEC) and its prevalence in food samples. His ongoing study on the serotype distribution of STEC in raw animal and plant-based food samples from Kocaeli Province has already started to shape food safety protocols in the region. Through molecular diagnostic techniques, particularly in pathogen identification, Adem has contributed to the development of more accurate and reliable methods of foodborne pathogen detection, ultimately aiming to improve food safety. His research is poised to have a lasting influence on the way pathogens are detected and managed in food production and consumption.

Accolades and Recognition 🏅

Adem’s research has earned him recognition within the academic community. His work on the detection of bovine and porcine species in foods containing animal gelatin, published in Food Analytical Methods, was highly praised for its application of the Q-Exactive ORBITRAP device, offering new insights into food authenticity testing. Additionally, his paper on the prevalence and serotype distribution of STEC in raw food samples was published in Food Control and has garnered significant attention due to its practical implications for food safety in Türkiye. Though still in the early stages of his career, his published works are laying a foundation for future recognition and awards.

Impact and Influence 🌍

The impact of Adem’s work on foodborne pathogen research cannot be overstated. His contributions to enhancing food safety through advanced diagnostic tools have already begun to influence both the academic and industry sectors. By identifying critical risk factors for foodborne illnesses and refining detection methods, Adem is playing a pivotal role in shaping safer food handling and processing practices. His work is not just contributing to the scientific community but is also being adopted by local food producers, creating a bridge between research and industry. His ability to collaborate with labs, local food producers, and other institutions demonstrates his leadership potential and influence in the field.

Legacy and Future Contributions 🔮

Adem Soycan’s research journey is just beginning, but his dedication to food safety, especially in the realm of microbiology, positions him for a promising career. In the future, he intends to continue refining pathogen detection methods and explore emerging technologies in molecular diagnostics. Adem envisions a future where his work on STEC will contribute significantly to global food safety standards, particularly in countries with emerging food safety challenges. His legacy will likely be one of improving food safety on a global scale, advancing diagnostic capabilities, and ensuring healthier food systems for generations to come.

Conclusion 🎉

Adem Soycan has already made significant contributions to the fields of microbiology and food safety, and his future in the scientific community looks exceedingly bright. His deep understanding of foodborne pathogens, especially Shiga Toxin-Producing Escherichia coli, combined with his innovative use of molecular techniques, has enabled him to make lasting impacts in both academia and industry. With a promising research trajectory and the potential to influence food safety practices worldwide, Adem is poised to become a leading figure in his field. His commitment to improving food safety, supported by his growing body of published work, cements his place as an emerging leader in microbiological research.

Dr. Yanfen Wang | Motivation and Employee Engagement | Best Researcher Award

Dr. Yanfen Wang | Motivation and Employee Engagement | Best Researcher Award

University of Science and Technology of China (USTC), China

Author Profile

Google Scholar 

🎓 Early Academic Pursuits

Yanfen Wang’s academic journey is marked by her unwavering commitment to understanding and advancing knowledge in the field of Business Administration. She began her formal higher education at Xi’an International Studies University in 2014, where she pursued a Bachelor’s degree in Marketing. Her dedication and passion for business strategy and organizational behavior soon led her to enroll in a Master’s program in Business Administration at the same institution. During this time, she studied under Professor Zizhen Geng, who played a crucial role in shaping her early research direction, particularly in team dynamics and creativity within organizational contexts.

This foundation set the stage for her doctoral journey at the University of Science and Technology of China (USTC)—one of China’s most prestigious research institutions—where she embarked on her Ph.D. in Business Administration in 2022 under the mentorship of Professor Qingxiong Weng. Her doctoral studies mark a significant transition into more rigorous and high-impact research, focusing on workplace psychology, employee behavior, and leadership dynamics.

💼 Professional Endeavors

Yanfen Wang’s professional journey as an academic has been heavily research-oriented, marked by her active involvement in both theoretical development and empirical investigation in the field of organizational behavior. Despite being a current Ph.D. candidate, she has already authored and co-authored several impactful papers in reputable international journals.

Her involvement in ongoing research collaborations—with both her former advisor, Professor Geng, and current mentor, Professor Weng—demonstrates her ability to bridge academic theory with practical implications. She has delved into pressing workplace issues such as leader-member exchange (LMX), paradoxical leadership, and team creativity, offering nuanced perspectives and empirical evidence that contribute meaningfully to business psychology literature.

Her growing portfolio of conference presentations at the Academy of Management (AOM) meetings further reflects her standing in the global academic community. Notably, she has presented three times at AOM (2021, 2023, and 2024), with one of her works being recognized with a Best Paper Notification in the OB Division—a testament to the quality and relevance of her research.

🧠 Contributions and Research Focus

Yanfen’s research contributions explore the intricacies of employee behavior and workplace dynamics, particularly in the Chinese organizational context. A core theme running through her publications is how leadership behaviors, both constructive and paradoxical, influence employee outcomes—ranging from creativity and motivation to counterproductive behaviors.

One of her notable studies, “Catching up or putting them down?”, published in Personality and Individual Differences, investigates how employees react to highly conscientious coworkers—shedding light on social comparison mechanisms and interpersonal dynamics in workgroups. Her co-authored paper on “LMX ambivalence” in Applied Psychology dissects the dual-edge consequences of inconsistent leader behavior, identifying its potential to deplete relational energy and trigger counterproductive actions.

In her work in progress, she is tackling bold questions like “Cheating from dominating?”, where she examines how dominant leadership traits can inadvertently push employees toward unethical behaviors—highlighting her interest in the darker side of organizational psychology.

🏆 Accolades and Recognition

Though still early in her academic career, Yanfen has garnered impressive accolades. Her Best Paper Notification from the AOM’s Organizational Behavior Division is a significant early recognition that places her among promising young scholars in the field. Moreover, her role as corresponding author on several publications—an uncommon feat for a doctoral student—reflects the high level of trust and credibility she has earned from her collaborators.

Her Google Scholar profile further reinforces her academic impact, showcasing her citations and growing influence within the research community.

🌏 Impact and Influence

Yanfen Wang’s research resonates deeply in both academic and practical circles. Her focus on team dynamics, leadership styles, and employee behavior offers actionable insights for HR professionals, corporate leaders, and organizational consultants seeking to build more effective and ethical workplace cultures. Her empirical work, rooted in both Western theories and Chinese workplace realities, provides a culturally grounded perspective that enriches global organizational behavior scholarship.

Her multi-methodological expertise—ranging from SPSS and Stata to Mplus, Amos, and fsQCA—also showcases her versatility in tackling complex behavioral phenomena using robust analytical techniques. This skill set makes her well-positioned to produce rigorous and policy-relevant research in both academia and industry contexts.

🌟 Legacy and Future Contributions

Looking ahead, Yanfen Wang is poised to become a thought leader in organizational psychology and business administration. Her research trajectory suggests a growing interest in the ethical and psychological implications of leadership, and her ability to interrogate both the motivational and adverse effects of workplace behaviors will continue to shape conversations in organizational studies.

Her evolving body of work contributes not only to theory development but also to practical frameworks that managers and organizational developers can use to create healthier, more transparent, and performance-enhancing workplaces.

If her early achievements are any indication, Yanfen is set to leave a lasting impact on the academic world, with a legacy rooted in intellectual curiosity, methodological rigor, and a deep commitment to advancing human potential in organizational settings. ✨

Motivation and hindrance: The mixed blessing of paradoxical leader behaviour for workplace creativity in China

Authors: Z. Geng, Y. Wang, Y. Fan, C. Shan
Journal: Asia Pacific Business Review
Year: 2023

Motivating R&D team creativity: the social cognitive effect of external developmental feedback and internal goal interdependence

Authors: Z. Geng, Y. Wang, J. Xue, H. Tang, H. Liu
Journal: R&D Management
Year: 2022

Diminished relational energy: How and when LMX ambivalence leads to leader‐directed counterproductive work behavior

Authors: L. Chen, Q. Weng, A. Popelnukha, H. Jiang, Y. Wang
Journal: Applied Psychology
Year: 2025

Catching up or putting them down? An investigation of employee divergent reactions to coworker conscientiousness

Authors: Q. Weng, Y. Wang, X. Wang, H. Qin
Journal: Personality and Individual Differences
Year: 2025

Navigating the Paradox of Originality and Usefulness: The Roles of Distinct Error Climates in Fostering Team Radical Creativity

Authors: Z. Geng, M. Xiao, H. Wang, J. Xue, Y. Wang
Journal: Creativity and Innovation Management
Year: 2025

Dr. Youmin Zhu | Innovative Leadership | Best Researcher Award

Dr. Youmin Zhu | Innovative Leadership | Best Researcher Award

Shanghai AZ Science and Technology Co., Ltd.

Author Profile

Orchid

🌱 Early Academic Pursuits

From the very beginning of his academic journey, Dr. Youmin Zhu demonstrated an exceptional passion for biological sciences. His intellectual curiosity led him to pursue a Ph.D. in biological sciences, where he laid a solid foundation in molecular biology, biotechnology, and pharmacology. During his doctoral years, he cultivated a deep interest in cutting-edge therapeutic strategies, particularly focusing on emerging protein degradation technologies and the role of bioactive peptides. His academic rigor and scientific curiosity propelled him to explore innovative modalities that bridged traditional research with real-world applications in drug and skincare development. These formative experiences not only enriched his technical skills but also instilled a vision to contribute meaningfully to both science and society.

🧪 Professional Endeavors

Now serving as the R&D President and Chief Scientist at Shanghai AZ Science and Technology Co., Ltd., Dr. Zhu has emerged as a visionary leader in the field of biotechnology. Under his guidance, the organization has completed over 20 major R&D projects, encompassing the development of peptide PROTACs-based skincare ingredients, enzymes, and probiotics. These endeavors reflect not only his scientific expertise but also his ability to translate theoretical concepts into commercial and therapeutic innovations.

Dr. Zhu’s strategic direction in the biotechnology sector has turned his company into a powerhouse of innovation, where the fusion of peptide-based therapeutics and skincare science is leading to transformative solutions. His work has bridged academic excellence with industrial application, enabling breakthroughs in precision medicine and advanced cosmeceuticals.

🔬 Contributions and Research Focus

Dr. Zhu’s research focus lies at the intersection of molecular biology, pharmacological innovation, and cosmetic science, with a central emphasis on peptide PROTACs (Proteolysis Targeting Chimeras). His pioneering efforts in this area have highlighted the multi-targeting potential of peptides, their biodegradability, low toxicity, and modular design, all of which present significant advantages over conventional small molecules and antibodies.

One of his most notable contributions is the publication of the article titled “The Peptide PROTAC Modality: A New Strategy for Drug Discovery” in MedComm (2025), an SCI-indexed journal with an impressive impact factor of 10.7. This work has been widely recognized in the scientific community and is already making waves in discussions around next-generation therapeutic strategies. The article has been cited across multiple domains, further demonstrating its relevance and value in ongoing pharmaceutical research.

With a total of over 10 scientific publications, Dr. Zhu has consistently contributed to scholarly literature and advanced dialogue in biotherapeutics. In addition, he holds 18 authorized patents in China, such as Patent No. CN202410445356.X, further underscoring his commitment to translating innovation into intellectual property and practical applications.

🏆 Accolades and Recognition

Dr. Zhu’s groundbreaking work has not gone unnoticed. His scientific and entrepreneurial achievements have earned him recognition within academic, industrial, and international circles. In addition to being a contributing scientist to impactful research, he has also been actively involved in collaborative projects with prestigious institutions including Fudan University, Shanghai Jiao Tong University, and Zhejiang University.

He is also an esteemed member of professional networks such as the Chinese Overseas Alliance and the Chinese Doctoral Alliance, where he continues to contribute to thought leadership and global knowledge exchange.

Furthermore, his work was recently highlighted in a widely circulated WeChat feature and an official PDF document of professional certification, showcasing his influence in both academic and industrial spheres.

🌍 Impact and Influence

Dr. Zhu’s influence extends beyond scientific circles. His work on peptide PROTACs is helping redefine how we understand and treat complex diseases. By leveraging the natural degradation mechanisms of the body through targeted proteolysis, his innovations are creating new avenues for the treatment of conditions previously considered untreatable.

Equally impressive is his impact on precision skincare, where bioengineered peptide-based compounds are providing customized, low-toxicity solutions for skin health. This cross-disciplinary impact, from health to beauty, positions Dr. Zhu as a transformative figure in the biotech and wellness industries.

His articles, particularly those involving collaborative authorship with Yu Dai and Yuncai Tian, have sparked global interest, and the citation of his MedComm article continues to grow. These ripple effects reflect the profound scientific and commercial value of his work.

🌟 Legacy and Future Contributions

As Dr. Zhu continues to push boundaries, the future of peptide-based therapeutics and cosmeceuticals looks increasingly promising. He is paving the way for a new era of precision medicine, where treatments are not only more effective but also safer and more sustainable.

Looking ahead, Dr. Zhu plans to scale his innovations globally and expand his company’s reach into international markets, bringing Chinese biotechnology to the global stage. His future goals include mentoring young scientists, fostering new academic-industry partnerships, and developing a global research ecosystem centered on peptide technologies.

Through his unwavering dedication and strategic foresight, Dr. Youmin Zhu is building a legacy that will inspire a generation of researchers and innovators. His contributions are not only advancing science but also shaping the future of healthcare and skincare for the better. 🌐

The Peptide PROTAC Modality: A New Strategy for Drug Discovery

Authors: Youmin Zhu, Yu Dai, Yuncai Tian
Journal: MedComm
Year: 2025

New Nobel Prize MicroRNA Technology Is Opening up a New Era of Precision Skincare

Authors: Youmin Zhu, Yu Dai, Xiaojing Wang, Shengjie Zhu, Yuncai Tian, Yong Tian
Journal: Advanced Journal of Nursing
Year: 2025

New peptide PROTAC is triggering a revolution in precise targeted skincare

Authors: Youmin Zhu, Yu Dai, Yuncai Tian, Yong Tian
Journal: Preprint (platform not specified)
Year: 2024

Advances in CRISPR/Cas9

Authors: Youmin Zhu, Syed Hassan
Journal: BioMed Research International
Year: 2022

Comparative Transcriptomics Reveals Jasmonic Acid-Associated Metabolism Related to Cotton Fiber Initiation

Authors: Liman Wang, Youmin Zhu, Wenjing Hu, Xueying Zhang, Caiping Cai, Wangzhen Guo
Journal: PLOS ONE
Year: 2015

Prof Maxime Breban | Prix du meilleur article de rechercher | Best Research Article Award

Prof Maxime Breban | Prix du meilleur article de rechercher

Université de Versailles-Saint-Quentin, France

Author Profile

Scopus 

Early Academic Pursuits 🎓

Professor Breban embarked on his medical journey at Paris hospitals, earning his Doctor of Medicine (MD) degree between 1984 and 1990. His passion for immunology and rheumatology led him to pursue a Doctorate (PhD), which he completed in 1994 under the auspices of the French National Institute for Medical Research. During this period, he honed his expertise in immuno-rheumatology, laying a solid foundation for his future endeavors.igasconference.com

Professional Endeavors 🏥

Following his PhD, Professor Breban undertook a post-doctoral fellowship at the Harold Simmons Research Center, University of Texas, Dallas, USA, from 1990 to 1993, under the mentorship of Professor Joel D. Taurog. This international experience enriched his research perspective and expertise. Upon returning to France, he served as a clinical fellow and subsequently as Associate Professor of Immunology at Cochin Hospital, Paris, from 1993 to 2002. In 2002, he joined the Rheumatology Division of Ambroise Paré Hospital in Boulogne-Billancourt as a Professor of Rheumatology and ascended to the role of Head of the Department in 2011. Concurrently, he has been directing a research team focused on chronic inflammation in rheumatic disorders, which transitioned from the Cochin Institute to the Faculty of Simone Veil-Santé in 2013.igasconference.com

Contributions and Research Focus 🔬

Professor Breban’s research primarily centers on the immunogenetics of ankylosing spondylitis and related spondyloarthritis. He has been the principal investigator and coordinator for numerous clinical and basic research projects. Over the past two decades, he has contributed to over 100 original papers and 40 review articles in the field of SpA. His work has significantly advanced the understanding of the genetic and environmental factors contributing to SpA, including the role of the microbiome in disease pathogenesis.igasconference.com

Accolades and Recognition 🏆

Throughout his illustrious career, Professor Breban has received several prestigious awards, including the American College of Rheumatology Fellowship Award for Excellence in Scientific Research in 1992 and the Guillaumat-Piel Prize from the Foundation for Medical Research in 2018. These accolades underscore his substantial contributions to rheumatology research and his dedication to advancing medical science.igasconference.com

Impact and Influence 🌍

Professor Breban’s influence extends beyond his research contributions. He has played pivotal roles in various scientific committees and societies, including serving as President of the Scientific Committee of the French Rheumatology Society from 1998 to 2004 and as a member of the Scientific Board of the French National Research Agency from 2012 to 2013. His involvement in these organizations has shaped research agendas and fostered collaborations within the rheumatology community.

Legacy and Future Contributions 🚀

As a dedicated educator, Professor Breban has been imparting knowledge in rheumatology to medical students since 1993 and has been involved in various master’s programs and university diplomas related to immunology and rheumatology. His commitment to teaching ensures the cultivation of future generations of rheumatologists. Looking ahead, Professor Breban continues to lead research initiatives aimed at unraveling the complexities of chronic inflammatory diseases, with the goal of developing innovative therapeutic strategies and improving patient outcomes.

In summary, Professor Maxime Breban’s career is marked by a profound dedication to the study and treatment of rheumatic diseases. His extensive research, leadership roles, and commitment to education have left an indelible mark on the field of rheumatology, promising continued advancements in understanding and managing these complex conditions.

📝Notable Publications

Interleukin 17-producing C-C motif chemokine receptor 6 + conventional CD4+ T cells are arthritogenic in an animal model of spondyloarthritis


Authors: M. Beaufrère, Marie; M. Jacoutot, Manon; M.A. Breban, Maxime A.; S. Glatigny, Simon
Journal: Journal of Autoimmunity
Year: 2025

 Microbiota in spondyloarthritis: Where are we?

Authors: M.A. Breban, Maxime A.; M. Beaufrère, Marie; M. Jacoutot, Manon; S. Glatigny, Simon
Journal: Not provided
Year: Not provided

What is a severe axial spondyloarthritis?

Authors: F. Costantino, Félicie; M.A. Breban, Maxime A.; M.A. D’Agostino, Maria Antonietta
Journal: Not provided
Year: Not provided

 TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis

Authors: M. Lauraine, Marc; M. de Taffin de Tilques, Maxence; D. Melamed-Kadosh, Dganit; L.M. Araujo, Luiza M.; M.A. Breban, Maxime A.
Journal: Arthritis Research and Therapy
Year: 2024

Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshop

Authors: D. Wendling, Daniel; M.A. Breban, Maxime A.; F. Costantino, Félicie; F.M. Verhoeven, Frank M.; C. Prati, Clément
Journal: Not provided
Year: Not provided